Patents by Inventor Craig Rosenfeld

Craig Rosenfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS
    Publication number: 20230172940
    Abstract: Provided herein is a method of extending the lifespan of an organism comprising administering to the organism an effective amount of a ferroptosis inhibitor. Also provided are compositions for extending lifespan comprising ferroptosis inhibitors.
    Type: Application
    Filed: January 17, 2023
    Publication date: June 8, 2023
    Applicant: COLLABORATIVE MEDICINAL DEVELOPMENT, LLC
    Inventors: Ashley Bush, Craig Rosenfeld, Kay Noel
  • Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders
    Publication number: 20220144826
    Abstract: The present application discloses heteroaromatic and heterobicyclic aromatic derivative compounds and compositions, and methods for treating ferroptosis-related disorders and diseases inpatients using the compounds and compositions as disclosed herein.
    Type: Application
    Filed: March 10, 2020
    Publication date: May 12, 2022
    Applicant: COLLABORATIVE MEDICINAL DEVELOPMENT, LLC
    Inventors: John Warner, Carmen Baldino, Laura Muollo, John Lee, Srinivasa Cheruku, Rowan Walker, James Siedlecki, John Proudfoot, Shawn Johnstone, Mehdi Numa, Craig Rosenfeld
  • Dihydro-6-azaphenalene derivatives for the treatment of CNS, oncological diseases and related disorders
    Patent number: 10047089
    Abstract: In one embodiment, the present application discloses 2-aza-, 2-oxa- and 2-thia-2,3-dihydro-6-azaphenalene compounds and compositions, and methods for treating a neurological disease in a patient in need thereof using the compounds and compositions as disclosed herein.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: August 14, 2018
    Assignee: Collaborative Medicinal Development, LLC
    Inventors: John C. Warner, Jeffery Allen Gladding, Srinivasa R. Cheruku, Dieu Nguyen, Jean R. Loebelenz, James J. Norman, Sambaiah Thota, John W. Lee, Craig Rosenfeld
  • Dihydro-6-Azaphenalene Derivatives for the Treatment of CNS, Oncological Diseases and Related Disorders
    Publication number: 20140094487
    Abstract: In one embodiment, the present application discloses 2-aza-, 2-oxa- and 2-thia-2,3-dihydro-6-azaphenalene compounds and compositions, and methods for treating a neurological disease in a patient in need thereof using the compounds and compositions as disclosed herein.
    Type: Application
    Filed: November 8, 2013
    Publication date: April 3, 2014
    Applicant: Warner Babcock Institute for Green Chemistry, LLC
    Inventors: John C. Warner, Jeffrey Allen Gladding, Srinivasa R. Cheruku, Dieu Nguyen, Jean R. Loebelenz, James J. Norman, Sambaiah Thota, John W. Lee, JR., Craig Rosenfeld